Skip to Content

C171 (Darifenacin Hydrobromide Extended-Release 15 mg)

Pill with imprint C171 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 15 mg. It is supplied by Par Pharmaceutical, Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C171

Darifenacin hydrobromide extended-release 15 mg C171

Darifenacin Hydrobromide Extended-Release

Imprint
C171
Strength
15 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
10370-0171
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromellose 2208 (3 mPa.s), lactose monohydrate, magnesium stearate, polyvinyl alcohol, magnesium silicate, polyethylene glycol, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C171"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.